Tag: Pimavanserin

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Pimavanserin

Global Parkinson's Disease Market Growth Rate And Recent Trends By Top Vendors:Acorda ...

Added to Collection on: 2021-01-16 17:46:46

Tags for this article:

Neurological disorders
Branches of biology
Health sciences
Neurodegenerative disorders
Dopamine reuptake inhibitors
Rare diseases
Geriatrics
Parkinson's disease
Psychiatric diagnosis
Amantadine
Pimavanserin
Acorda Therapeutics

Click the tags to see associated articles and topics

View Article Details
Report: 2021 Could Represent a Major Shift in Central Nervous System Therapeutics

Added to Collection on: 2021-03-08 14:03:45

Tags for this article:

Monoclonal antibodies
Life Sciences
Drugs
Aducanumab
Organic compounds
Biogen
Alzheimer's disease
Lumateperone
Pimavanserin
Neurocrine Biosciences
genuity capital

Click the tags to see associated articles and topics

View Article Details
Acadia shares plunge after unexpected FDA feedback

Added to Collection on: 2021-03-09 17:15:00

Tags for this article:

Organic compounds
Chemical compounds
Acadia Pharmaceuticals
Pimavanserin
Food and Drug Administration
Psychosis
Antipsychotic
Chemistry

Click the tags to see associated articles and topics

View Article Details
Acadia Stock Is Plunging Again. The FDA Rejected a Drug Application.

Added to Collection on: 2021-04-05 13:52:30

Tags for this article:

Organic compounds
Chemical compounds
5-HT2A antagonists
Ureas
Pimavanserin
Piperidines
Food and Drug Administration
Dementia
Psychiatry
Acadia Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Acadia, with drug application rejected, calls out FDA for backtracking

Added to Collection on: 2021-04-05 16:07:30

Tags for this article:

Health sciences
Health
Acadia Pharmaceuticals
Food and Drug Administration
Pimavanserin
Clinical trial
Dementia
Psychosis
Indication
Pharmaceutical industry

Click the tags to see associated articles and topics

View Article Details
ACADIA Pharmaceuticals Stock Price: $28 Target (Down From $50) By Morgan Stanley

Added to Collection on: 2021-04-06 11:58:29

Tags for this article:

Acadia Pharmaceuticals
Organic compounds
Chemical compounds
Pimavanserin
Psychosis
Chemistry

Click the tags to see associated articles and topics

View Article Details
Provention Bio latest drugmaker flagged for 'deficiencies' in FDA approval application

Added to Collection on: 2021-04-09 14:48:45

Tags for this article:

Organic compounds
Chemical compounds
Teplizumab
Food and Drug Administration
Pimavanserin
Chemistry
provention bio
Provention

Click the tags to see associated articles and topics

View Article Details
Research team works to develop Parkinson's treatment

Added to Collection on: 2021-04-15 15:22:30

Tags for this article:

Drugs
Branches of biology
Chemical compounds
Parkinson's disease
Catecholamines
L-DOPA
Prodrugs
Antidepressant
Vilazodone
Serotonin
Levodopa-induced dyskinesia
Pimavanserin

Click the tags to see associated articles and topics

View Article Details
Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative ...

Added to Collection on: 2021-07-14 12:56:15

Tags for this article:

Psychiatry
Branches of biology
Neuroscience
Psychiatric diagnosis
Psychopathology
Aging-associated diseases
Cognitive disorders
Learning disabilities
Pimavanserin
Acadia Pharmaceuticals
Antipsychotic
Dementia
Acadia Pharmaceuticals Inc

Click the tags to see associated articles and topics

View Article Details
Parkinson's Drug Tied to Increased Hospitalizations, Death | MedPage Today

Added to Collection on: 2021-08-17 21:22:30

Tags for this article:

Psychiatry
Branches of biology
Psychiatric diagnosis
Neuroscience
Aging-associated diseases
Cognitive disorders
Learning disabilities
Pimavanserin
Atypical antipsychotic
Antipsychotic
Parkinson's disease
Psychosis
Y. Joseph Hwang
Farwa Ali

Click the tags to see associated articles and topics

View Article Details